Objective To evaluate the association between vitamin D receptor (VDR) BsmI gene polymorphism and the risk of end-stage renal disease (ESRD). Methods All eligible studies were included in our meta-analysis of a search of the PubMed, Embase, Cochrane and China National Knowledge Infrastructure (CNKI) databases according to predefined criteria. The fixed-effects or, in the presence of heterogeneity, random-effects models were used to calculate the pooled odds ratio (OR) and corresponding 95% confidence interval (CI). Materials Six studies including 863 patients and 1,063 controls were recruited for the analysis of the association between the VDR BsmI gene polymorphism and the risk of ESRD. Results The B allele/BB genotype was not associated with the ESRD risk in the overall population, Caucasians or Asians (overall population: p=0.492 and 0.382, Caucasians: p=0.765 and 0.522, Asians: p=0.607 and 0.481). The Bb/bb genotype was also not associated with the risk of ESRD in the overall population, Caucasians or Asians (overall population: p=0.556 and 0.166, Caucasians: p=0.770 and 0.965, Asians: p=0.411 and 0.098). The exclusion of any single study had little impact on the p value in the overall population. No evidence of publication bias was observed. Conclusion VDR BsmI gene polymorphism appears to not be associated with the risk of ESRD in the overall population, Caucasians or Asians. However, more studies should be performed in the future.
Introduction
End-stage renal disease (ESRD) is the complete or almost complete failure of the kidneys to function (1) . The number of ESRD patients is increasing worldwide, with a growing demand for health care services, including renal transplantation and dialysis (2) . Patients with ESRD exhibit significantly increased morbidity and mortality. The most common causes of ESRD are diabetes mellitus and hypertension (3) . However, many cases remain unexplained. Patients suffering from ESRD display enhanced genomic damage, and DNA repair gene polymorphisms can affect the capacity for DNA repair and modulate the susceptibility to ESRD (4) . A number of studies have suggested that genetic factors are involved in the onset of ESRD (5) (6) (7) .
ESRD is associated with vitamin D deficiency and is a disorder that impairs all metabolic processes associated with vitamin D (8) . Meanwhile, vitamin D deficiency is associated with a range of complications in patients with renal disease. Therefore, vitamin D supplementation is frequently used as an adjunct therapy in patients with renal disease, particularly ESRD (8) . The actions of vitamin D are primarily mediated by vitamin D receptors (VDRs) (9) . Clinical studies have shown treatment with VDR activators to be associated with better prognoses of ESRD (8) . BsmI, a VDR, is well-documented to be associated with survival in dialysis populationa (10) . Furthermore, it has been reported that non-BB variants of VDR BsmI gene polymorphism are associated with an increased risk of developing hypercalcemia in peritoneal dialysis patients (11) . In terms of the abovementioned data, we hypothesized that VDR BsmI gene polymorphism may be associated with susceptibility to ESRD. The past few years have witnessed increasing interest in testing this hypothesis. However, the results remain controversial among the reported studies (10, (12) (13) (14) (15) (16) , and no pooled analyses have been conducted. Improved understanding of this issue may have important clinical implications, given the possibility that VDR BsmI gene polymorphism may be an indicator predicting the onset of ESRD. With the accumulating evidence of individual studies, we conducted a meta-analysis to investigate the association between VDR BsmI gene polymorphism and the risk of ESRD with the aim of providing more reliable findings on the significance of the association.
Materials and Methods

Publication search and inclusion criteria
The published literature investigating the association between VDR Bsml gene polymorphism and the risk of ESRD was searched through April 2013 using the PubMed, Embase, Cochrane and China National Knowledge Infrastructure (CNKI) databases. No restrictions were imposed on the search language. The used search terms were as follows: 1) end-stage renal disease, ESRD, kidney failure, renal failure; 2) vitamin D, BsmI, gene polymorphism. The reference lists of the retrieved reviews and papers were also scanned.
The studies were considered eligible if they met the following criteria: 1) a case-controlled study; 2) the outcome of interest was ESRD; 3) a minimum of two comparison groups (ESRD group vs. control group); and 4) the genotype distributions of the control groups were in HardyWeinberg equilibrium (HWE). When the same participants were included in more than two publications, we chose the study with the most complete analysis.
Data extraction
We extracted the study characteristics from each study. The data were recorded as follows: first author's last name, year of publication, region, ethnicity, number of cases and controls for the VDR BsmI genotype. The frequency of the B allele was calculated for bothe the case and control groups from the corresponding genotype distribution. Two authors independently performed the data extraction, with any disagreements resolved by discussion.
Statistical methods
The odds ratio (OR) was used to measure the association between the VDR BsmI gene polymorphism and the risk of ESRD across the studies. The heterogeneity of the OR among the studies was tested using the Q statistic (with a significance level at p<0.10). 
Results
Study characteristics and meta-analysis results
We retrieved 57 relevant citations from the electronic search. Of these, 51 studies were excluded, including 26 papers that were editorials, reviews or case reports, 22 papers that showed no results regarding the VDR BsmI gene or outcomes, two papers that reported the progression of the VDR BsmI expression to disease and one paper that lacked a control group. Ultimately, six papers were included in our meta-analysis ( Fig. 1) . Three studies were conducted in Asians and three in Caucasians. The retrieved data were recorded as follows: first author's surname, publication year, the number of patients and controls, the frequency of the B allele in the patients and controls and HWE (Table 1) .
A total of 863 patients and 1,063 controls were included. The average frequency of the B allele was 28.80% in the Asian patients and 18.34% in the Asian controls. In the Caucasians, the average frequency of the B allele was 41.16% in the patients and 39.85% in the controls. The ratio of patients/controls for the average frequency of the B allele in the Asians was significantly higher than that observed in the Caucasians (Asians: patients/controls=1.57; Caucasians: patients/controls=1.03).
No significant associations were oberved between the B allele/BB genotype and the risk of ESRD in the overall population, Caucasians or Asians (overall population: p= 0.492 and 0.382, Caucasians: p=0.765 and 0.522, Asians: p= 0.607 and 0.481) ( Fig. 2, 3 ; Table 2 ). The Bb/bb genotype was also not associated with the risk of ESRD in the overall population, Caucasians or Asians (overall population: p= Table 2 ). In the sensitivity analysis, the exclusion of any single study had little impact on the p value in the overall population (Table 2) . 
Bias diagnostics
Discussion
The BsmI identified in the untranslated 3' region of the VDR locus defines the B and b alleles that determine the differences in the VDR gene expression and ultimately have functional consequences (17) . It is well-documented that VDR BsmI gene polymorphism is associated with the risk of several cancers (18) (19) (20) . In patients with chronic kidney disease, VDR BsmI gene polymorphism is reported to be associated with the onset of various complications, such as cardiovascular disease (10) . However, this meta-analysis did not yield expected results.
Our investigation indicated that VDR BsmI gene polymorphism was not associated with susceptibility to ESRD in the overall population, Caucasians or Asians. The sensitivity analysis did not change the results of the overall population, and no publication bias was observed. Nevertheless, the results should be interpreted with great caution due to the limited number of studies (n=6).
Several factors may account for the lack of contribution of VDR BsmI gene polymorphism to the onset of ESRD. First, although VDR BsmI gene polymorphism is involved in the regulation of mRNA stability and influences transcription and bone mineral density (21, 22) , BsmI lies in the intronic region considered to be a silent polymorphism, without changing the amino acid sequence of the encoded protein (23) . In this sense, the effects of BsmI gene polymorphism on the VDR expression are at least not direct and may not be adequately intensive to affect the susceptibility to ESRD. Second, it is well accepted that gene polymorphisms exhibit their clinical effects under the influence of environmental and coexisting genetic factors (24) . One study (13) showed that ESRD patients with FoKI and BsmI polymorphisms are at a 4.33-fold increased risk. In that study, a haplotype analysis revealed that individuals with the a/t/F/b haplotype had a 11.0-fold increased risk. This indicates the existence of gene interactions. In our metaanalysis, the ratio of patients/controls for the average frequency of the B allele in Asians was obviously higher than OR: odds ratio, CI: confidence interval that observed in Caucasians, which suggests that ethnic differences affect the final conclusions. Regrettably, we were unable to conduct a combined analysis due to the lack of relevant data. Third, VDR BsmI gene polymorphism demonstrates inconsistent relationships with various causes of ESRD. For example, Rezende et al. (25) reported that no significant associations existed between VDR BsmI gene polymorphism and the risk of hypertensive disorders of pregnancy. Vedralová et al. (26) reported that VDR BsmI gene polymorphism is not associated with the risk diabetic nephropathy, whereas the BBFFAATt combination of the VDR gene is more frequent in diabetic patients than in In our investigation, only one study by Tripathi et al. (13) showed that VDR BsmI gene polymorphism is associated with susceptibility to ESRD. This is likely due to the fact that the majority of ESRD patients in that study had chronic glomerulonephritis, and patients with diabetes mellitus were excluded. However, another study (16) included in our analysis, in which patients with diabetes mellitus were excluded, found no marked associations between VDR BsmI gene polymorphism and the risk of ESRD. The remaining four studies included in our analysis did not provide information related to the excluded patients. Notably, Wang et al. (35) reported that VDR BsmI gene polymorphism is associated with the onset of type 1 diabetes mellitus in East Asians. Furthermore, Li et al. (36) reported that BsmI gene polymorphism is not associated with the risk of type 2 diabetes mellitus. Nevertheless, our investigation has important clinical implications in that comorbidities may not directly affect the association between VDR BsmI gene polymor-phism and the risk of ESRD. Further stratification studies should be performed in the future.
Our study has obvious strengths. A sensitivity analysis was performed in which the robustness of the results was demonstrated. No restrictions were imposed on the origin of the participants, which may allow for generalization of the results. However, several limitations should be considered. First, heterogeneity may have affected the results of our meta-analysis, although the random-effects model was used. Second, the specific cause of ESRD was lacking in some of the included studies; therefore, we were unable to conduct a subgroup analysis. Finally, although no evidence of publication bias was observed, the small number of studies decreases the statistical power.
Based on our findings, further studies should address the following issues: 1) elucidation of the impact of the interactions between BsmI and other VDR genes on the relationship between VDR BsmI gene polymorphism and the risk of ESRD; and 2) a subgroup analysis of the causes of ESRD with respect to the association between VDR BsmI gene polymorphism and the risk of ESRD.
In conclusion, this meta-analysis suggests that VDR BsmI gene polymorphism is not associated with susceptibility to ESRD in the overall population, Caucasians or Asians. However, due to the fact that only six studies were included, the results should be interpreted with great caution and more studies should be performed in the future.
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